Press release
Polyethylene Glycol Market to Reach New Heights by 2032 with Expanding Applications Across Pharmaceuticals and Industrial Sectors
✅Overview of the MarketAccording to the latest study by Persistence Market Research, the polyethylene glycol (PEG) market is poised for substantial growth over the next decade, driven by the increasing demand across pharmaceuticals, personal care, and industrial applications. Polyethylene glycol, a polyether compound, is widely used due to its water solubility, non-toxicity, and versatility in molecular weights. It finds extensive usage as a solvent, lubricant, dispersing agent, and surfactant in various sectors. The market's rising trajectory is closely linked to pharmaceutical and cosmetic manufacturers seeking safe, biocompatible compounds to meet consumer and regulatory expectations.
In terms of value, the global PEG market is expected to witness consistent growth through 2032, supported by rising healthcare expenditure, innovations in drug delivery systems, and increased use in skin creams, ointments, and laxatives. The pharmaceutical grade PEG dominates the market segment due to its crucial role in formulations like oral suspensions and injectables. Geographically, North America leads the market owing to its advanced pharmaceutical manufacturing base, strong R&D investment, and robust regulatory infrastructure. Additionally, growing demand for sustainable and green chemicals is leading companies to explore bio-based PEGs, which further strengthens the market outlook in developed regions.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/12541
✅Key Market Insights
➤ Rising adoption of PEG in pharmaceutical drug formulations enhances bioavailability and solubility of active compounds.
➤ The cosmetic and personal care industry heavily relies on PEGs for emollients and emulsifiers in creams and lotions.
➤ Industrial applications in lubricants, inks, ceramics, and anti-foaming agents are contributing to steady PEG demand.
➤ North America continues to dominate the market with expanding pharmaceutical and healthcare industries.
➤ Increasing innovation around biodegradable and bio-based PEGs aligns with sustainability goals and environmental regulations.
✅What are the key uses of polyethylene glycol in pharmaceuticals?
Polyethylene glycol is extensively used in the pharmaceutical industry due to its safety, biocompatibility, and solubility-enhancing properties. It acts as a base for ointments, a binder in tablets, a laxative in over-the-counter medications, and a carrier for drug delivery systems. PEG improves the absorption of active pharmaceutical ingredients (APIs) and ensures consistent drug performance. It is also used in injectable and topical medications. Its wide molecular weight range allows customization for specific applications, making PEG a highly versatile excipient in drug formulation and delivery technologies.
✅Market Dynamics
Drivers:
Key drivers for the PEG market include increased use in pharmaceutical and personal care products, rising global population, and growing demand for advanced drug delivery mechanisms. The push for efficient and biocompatible drug carriers has significantly boosted PEG's importance in the pharmaceutical sector. Additionally, its versatility across industrial applications like surfactants, lubricants, and chemical intermediates further supports market growth.
Restraint:
One major restraint is the growing concern about potential environmental impact and bioaccumulation of non-biodegradable PEGs. Additionally, fluctuations in raw material prices, especially those derived from petrochemical sources, may impact profitability for manufacturers. Stringent regulatory scrutiny around PEG quality, especially for medical and food-grade applications, could also pose challenges.
Opportunity:
Emerging opportunities lie in the development of bio-based polyethylene glycol made from renewable sources. With increasing global emphasis on sustainability, manufacturers are investing in green chemistry and environmentally friendly alternatives. Also, the rising demand from emerging economies for better healthcare infrastructure and cosmetic products opens up lucrative growth avenues.
✅Market Segmentation
The polyethylene glycol market is segmented based on form, grade, and end-use industry. By form, the market is divided into liquid, paste, and powder types. Liquid PEG dominates this segment due to its easier application in pharmaceuticals, cosmetics, and industrial formulations. Liquid PEG is preferred in skin creams, laxatives, and inks due to its high solubility and uniform viscosity.
By grade, the market is categorized into pharmaceutical, industrial, and cosmetic grades. Among these, the pharmaceutical grade PEG holds the largest market share, driven by its widespread use in medical formulations and regulatory approvals across global markets. Cosmetic-grade PEGs are also seeing increasing demand owing to their emollient and emulsifying properties in skincare and haircare products.
On the basis of end-use industry, the PEG market spans pharmaceuticals, personal care, chemical processing, industrial manufacturing, and others. The pharmaceutical segment is the most dominant, owing to the rising need for excipients in drug formulations and increased production of OTC medications. The personal care segment is also rapidly growing, driven by consumer preference for products with moisturizing and texture-enhancing ingredients.
✅Regional Insights
North America currently leads the global polyethylene glycol market, supported by robust pharmaceutical R&D, regulatory clarity, and advanced manufacturing capabilities. The United States, being a major player in the global healthcare and cosmetics industries, contributes significantly to regional dominance. Europe follows closely with strong demand from cosmetics and personal care sectors, particularly in France, Germany, and the UK.
The Asia Pacific region is anticipated to witness the fastest growth, driven by expanding healthcare infrastructure, rising consumer income, and increased industrial activities in China, India, and Southeast Asia. Government investments in public health and growing awareness of hygiene and skincare are further enhancing demand in these emerging markets. Latin America and the Middle East & Africa are gradually emerging markets, fueled by growing urbanization and rising pharmaceutical investments.
✅Competitive Landscape
The polyethylene glycol market is moderately fragmented, with global and regional players investing in capacity expansion, product innovation, and sustainability initiatives. Strategic partnerships and mergers are becoming common as companies seek to strengthen their global footprint and diversify their PEG offerings.
✅Company Insights
✦ Dow Chemical Company
✦ BASF SE
✦ Merck KGaA
✦ INEOS Oxide
✦ Liaoning Oxiranchem Inc.
✦ India Glycols Limited
✦ Lotte Chemical Corporation
✦ Croda International Plc
✦ Clariant AG
✦ KAORI CHEMICALS Pvt. Ltd.
✦ NOF Corporation
For Customized Insights on Segments, Regions, or Competitors, Request Personalized Purchase Options @ https://www.persistencemarketresearch.com/request-customization/12541
✅Key Industry Developments
One of the notable developments in the PEG market is the shift toward bio-based polyethylene glycol production. Companies like BASF and Croda International are investing in sustainable chemical processes that utilize plant-based feedstock instead of petroleum derivatives. These innovations align with global efforts to reduce carbon footprints and meet environmental standards.
Additionally, strategic partnerships between pharmaceutical giants and PEG manufacturers are accelerating innovation in drug formulation. Merck and Dow Chemical have collaborated with drug developers to create custom PEG derivatives that enhance bioavailability and drug stability. These collaborations ensure consistency in quality and long-term supply for critical applications, especially in injectable and oncology medications.
✅Innovation and Future Trends
The future of the polyethylene glycol market lies in advanced drug delivery systems, biodegradable PEGs, and personalized medicine. R&D is focusing on creating PEG derivatives tailored for specific applications such as PEGylated drugs, which improve drug solubility and reduce immunogenicity. This innovation will continue to support the pharmaceutical industry's movement toward more effective and targeted therapies.
In the industrial and personal care sectors, the emphasis is shifting to green chemistry and sustainable sourcing. The growing trend of using eco-friendly ingredients in skincare and cosmetic formulations is likely to push demand for natural or plant-derived PEGs. Smart PEG variants with self-healing, pH-responsive, and temperature-sensitive properties are also being explored for niche, high-value applications in biomedical engineering and high-performance coatings.
✅Explore the Latest Trending "Exclusive Article" @
• https://medium.com/@apnewsmedia/lime-market-growth-trends-and-forecast-analysis-2025-to-2032-d2cac52ae21f
• https://industrywire.news.blog/2025/06/29/lime-market-demand-driven-by-construction-and-agriculture/
• https://apsnewsmedia.blogspot.com/2025/06/lime-market-overview-with-key-industry.html
• https://www.manchesterprofessionals.co.uk/article/marketing-pr/96070/lime-market-size-share-and-future-opportunities
• https://vocal.media/stories/lime-market-dynamics-challenges-and-growth-factors
✅Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
✅About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polyethylene Glycol Market to Reach New Heights by 2032 with Expanding Applications Across Pharmaceuticals and Industrial Sectors here
News-ID: 4086338 • Views: …
More Releases from Persistence Market Research

C-Reactive Protein Testing Market Growth Forecast at 4.9% CAGR by Persistence Ma …
The C-reactive protein (CRP) testing market is a rapidly evolving segment of the global diagnostics industry, playing a pivotal role in the early detection, monitoring, and management of various health conditions, especially cardiovascular and inflammatory diseases. According to Persistence Market Research, the market is projected to grow from US$2.85 billion in 2025 to approximately US$3.98 billion by 2032, registering a CAGR of 4.9% during the forecast period.
This growth is fueled…

Tissue Culture Reagents Market Growth Forecast 2025-2032 at 7.2% CAGR, Valued at …
The global tissue culture reagents market is undergoing a transformative phase, driven by the growing demand for cell-based research, advancements in personalized medicine, and surging applications in regenerative therapies. With an estimated value of US$3.1 Bn in 2025 and a projected reach of US$5.3 Bn by 2032, the market is expected to grow at a CAGR of 7.2% during the forecast period, according to Persistence Market Research.
Shorter development cycles in…

Magnetoencephalography Market: Persistence Market Research Highlights Key Growth …
The global magnetoencephalography (MEG) market is experiencing significant momentum, poised to grow from US$ 319.9 Mn in 2025 to US$ 456.6 Mn by 2032, at a steady CAGR of 5.2%. MEG, a non-invasive neuroimaging technique that captures magnetic fields produced by neuronal activity, is reshaping diagnostics and treatment planning in neurological care. As demand for precise brain mapping grows, MEG is quickly transitioning from niche research tool to essential clinical…

Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…